Custom-Made vaccine trial aims to boost immune attack on aggressive breast cancer
Disease control
Recruiting now
This early-stage trial is testing a personalized vaccine called NECVAX-NEO1. It is given alongside standard chemotherapy and immunotherapy to patients with triple-negative breast cancer before surgery. The goal is to see if adding this custom-made vaccine, designed to target each…
Phase: PHASE1, PHASE2 • Sponsor: NEC Bio B.V • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC